| SAGE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SAGE shares outstanding history going back to 7/18/2014:
Also see: SAGE Market Cap History SAGE YTD Return |
| SAGE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SAGE Historical Shares Outstanding: +9.33% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAGE Stock Price Chart |
| About Sage Therapeutics Inc |
| Sage Therapeutics, Inc. is a biopharmaceutical company. Co. has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Co. is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. We show 45 historical shares outstanding datapoints in our coverage of SAGE's shares outstanding history. Understanding the changing numbers of SAGE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SAGE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SAGE by allowing them to research SAGE shares outstanding history as well as any other stock in our coverage universe. |
| SAGE Current Stock Quote |
Quotes delayed 20 minutes  Free SAGE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SAGE Share Performance |
| Shares Outstanding Peers |
| Sage Therapeutics (SAGE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SANA Shares Outstanding History SAVA Shares Outstanding History SBFM Shares Outstanding History SBPH Shares Outstanding History SBTX Shares Outstanding History SCPH Shares Outstanding History SCPS Shares Outstanding History SCTL Shares Outstanding History SCYX Shares Outstanding History SDC Shares Outstanding History More Healthcare companies » |
SAGE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
